Hysteroscopy Workup

  • Author: John C Petrozza; Chief Editor: Michel E Rivlin, MD   more...
 
Updated: Nov 17, 2011
 

Laboratory Studies

  • CBC: As in most surgical procedures, the CBC provides the surgeon with information regarding the patient's baseline status and, if blood loss is encountered, with an idea of how much blood loss is acceptable. A blood count in the reference range also ensures adequate oxygenation to all vital and healing tissues and an adequate immune response.
  • Blood typing and screening: With the risk of hemorrhage approaching 7-8% in some surgical hysteroscopic procedures, a sample in the blood bank increases the efficiency of access to replacement blood products if needed.
  • Electrolyte determinations: In patients with medical disorders that predispose them to metabolic abnormalities (eg, diuretic use), electrolytes should be tested preoperatively. Some surgeons routinely obtain baseline levels in case a significant deficit of distention medium occurs (especially with a hyposmolar solution), whereas most obtain electrolyte levels intraoperatively or postoperatively only if a clinically significant fluid deficit occurs. The ultimate decision should be based on the type of case, the surgeon's skill, the suspected fluid absorption, and the ability to accurately ascertain fluid deficits in the operating room.
  • Determination of human chorionic gonadotropin (hCG) levels: Determination of pregnancy status is mandatory in any woman of reproductive age.
  • Cervical cultures: Depending on the prevalence of chlamydia and gonorrhea in the population, this may be a worthwhile preoperative test. Also, if the patient is reporting a vaginal discharge, cultures and a wet smear for bacterial vaginosis and trichomoniasis are recommended.
  • Papanicolaou test (Pap smear): A normal finding on Pap smear, or at least an abnormal finding on Pap smear that has been appropriately evaluated, is required because trauma to the cervix may alter the appearance of any abnormalities.
Next

Imaging Studies

  • Hysterosalpingogram or sonohysterogram: For evaluating the uterine cavity and patency of fallopian tubes, hysterosalpingography is the superior study. However, to selectively look at the uterine cavity, sonohysterography or saline-infused sonography are superior. They have better negative and positive predictive values than those of hysterosalpingogram in determining the location and size of fibroids and endometrial polyps and for ascertaining the presence of most uterine anomalies, including septa, bicornuate uteri, didelphic uteri, and even dense adhesions.
  • CT scanning or MRI: These imaging studies are not usually needed unless the findings on sonohysterography or hysterosalpingography are inconclusive. MRI is a useful modality for examining the uterine fundus when distinguishing between a septate and bicornuate uterus.
Previous
Next

Diagnostic Procedures

Endometrial biopsy is indicated in perimenopausal/menopausal women and in women older than 35 years with irregular bleeding (eg, heavy menses, irregular spotting, prolonged menses) and in women with absent menses with at least 6 months of unopposed estrogen. It should be considered for women younger than 35 years who are suspected to have anovulatory bleeding, do not respond to medical therapy, or have prolonged unopposed estrogen exposure and for adolescent women with >2 year history of anovulatory bleeding, especially with risk factors (ie, obesity). In these women, the risk for endometrial hyperplasia or cancer is increased.

In any woman undergoing endometrial ablation, benign endometrial tissue should be pathologically confirmed.

Previous
Proceed to Treatment & Management
 
 
Contributor Information and Disclosures
Author

John C Petrozza  MD, Instructor, Department of Obstetrics and Gynecology, Harvard Medical School; Consulting Staff and Chief, Division of Reproductive Medicine and IVF, Vincent Memorial Obstetrics and Gynecology, Director, MGH Fertility Center, Massachusetts General Hospital

John C Petrozza is a member of the following medical societies: American College of Obstetricians and Gynecologists, American Medical Association, American Society for Reproductive Medicine, and Massachusetts Medical Society

Disclosure: Interlace Medical, Inc. Stock options Board membership

Coauthor(s)

Jill A Attaman, MD  Instructor in Obstetrics, Gynecology and Reproductive Biology, Harvard Medical School; Fellow, Reproductive Endocrinology and Infertility, Vincent Obstetrics and Gynecology Services, Massachusetts General Hospital

Jill A Attaman, MD, is a member of the following medical societies: American College of Obstetricians and Gynecologists, American Medical Association, and American Society for Reproductive Medicine

Disclosure: Nothing to disclose.

Specialty Editor Board

Thomas Michael Price, MD  Associate Professor, Division of Reproductive Endocrinology, Director of Reproductive Fellowship Training Program, Duke University Medical Center

Thomas Michael Price, MD is a member of the following medical societies: Alpha Omega Alpha, American College of Obstetricians and Gynecologists, American Medical Association, American Society for Reproductive Medicine, Association of Professors of Gynecology and Obstetrics, Endocrine Society, Phi Beta Kappa, Society for Gynecologic Investigation, Society for Reproductive Endocrinology and Infertility, and South Carolina Medical Association

Disclosure: Clinical Advisors Group Consulting fee Consulting; MEDA Corp Consulting Consulting fee Consulting; Gerson Lehrman Group Advisor Consulting fee Consulting; Adiana Grant/research funds PI

Francisco Talavera, PharmD, PhD  Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Medscape Salary Employment

Michel E Rivlin, MD  Professor, Department of Obstetrics and Gynecology, University of Mississippi School of Medicine

Michel E Rivlin, MD is a member of the following medical societies: American College of Obstetricians and Gynecologists, American Medical Association, Mississippi State Medical Association, and Royal College of Surgeons of Edinburgh

Disclosure: Nothing to disclose.

Frederick B Gaupp, MD  Consulting Staff, Department of Family Practice, Hancock Medical Center

Frederick B Gaupp, MD is a member of the following medical societies: American Academy of Family Physicians

Disclosure: Nothing to disclose.

Chief Editor

Michel E Rivlin, MD  Professor, Department of Obstetrics and Gynecology, University of Mississippi School of Medicine

Michel E Rivlin, MD is a member of the following medical societies: American College of Obstetricians and Gynecologists, American Medical Association, Mississippi State Medical Association, and Royal College of Surgeons of Edinburgh

Disclosure: Nothing to disclose.

Additional Contributors

The authors and editors of eMedicine gratefully acknowledge the contributions of previous authors Gretchen E H Makai, MD and Emily Sikking, MD to the development and writing of this article.

References

  1. Corfman RS. Indications for hysteroscopy. Obstet Gynecol Clin North Am. Mar 1988;15(1):41-9. [Medline].

  2. Shapiro BS. Instrumentation in hysteroscopy. Obstet Gynecol Clin North Am. Mar 1988;15(1):13-21. [Medline].

  3. American College of Obstetricians and Gynecologists. Hysteroscopy. ACOG Technical Bulletin Number 191-April 1994. Int J Gynaecol Obstet. May 1994;45(2):175-80. [Medline].

  4. Brill AI. Energy systems for operative hysteroscopy. Obstet Gynecol Clin North Am. Jun 2000;27(2):317-26. [Medline].

  5. Luciano AA. Power sources. Obstet Gynecol Clin North Am. Sep 1995;22(3):423-43. [Medline].

  6. Indman PD. Instrumentation and distention media for the hysteroscopic treatment of abnormal uterine bleeding. Obstet Gynecol Clin North Am. Jun 2000;27(2):305-15, vi. [Medline].

  7. Marlow JL. Media and delivery systems. Obstet Gynecol Clin North Am. Sep 1995;22(3):409-22. [Medline].

  8. Cooper JM, Brady RM. Late complications of operative hysteroscopy. Obstet Gynecol Clin North Am. Jun 2000;27(2):367-74. [Medline].

  9. Jansen FW, Vredevoogd CB, van Ulzen K, Hermans J, Trimbos JB, Trimbos-Kemper TC. Complications of hysteroscopy: a prospective, multicenter study. Obstet Gynecol. Aug 2000;96(2):266-70. [Medline].

  10. Cooper JM, Brady RM. Hysteroscopy in the management of abnormal uterine bleeding. Obstet Gynecol Clin North Am. Mar 1999;26(1):217-36. [Medline].

  11. March CM. Hysteroscopy. J Reprod Med. Apr 1992;37(4):293-311; discussion 311-2. [Medline].

  12. Bradley LD, Pasqualotto EB, Price LL. Hysteroscopic management of endometrial polyps. Obstet Gynecol. Apr 2000;95(4 Suppl 1):S23.

  13. van Dongen H, de Kroon CD, Jacobi CE, Trimbos JB, Jansen FW. Diagnostic hysteroscopy in abnormal uterine bleeding: a systematic review and meta-analysis. BJOG. Jun 2007;114(6):664-75. [Medline].

  14. de Kroon CD, de Bock GH, Dieben SW, Jansen FW. Saline contrast hysterosonography in abnormal uterine bleeding: a systematic review and meta-analysis. BJOG. Oct 2003;110(10):938-47. [Medline].

  15. Clark TJ, Voit D, Gupta JK, Hyde C, Song F, Khan KS. Accuracy of hysteroscopy in the diagnosis of endometrial cancer and hyperplasia: a systematic quantitative review. JAMA. Oct 2 2002;288(13):1610-21. [Medline].

  16. Gimpelson RJ. Hysteroscopic treatment of the patient with intracavitary pathology (myomectomy/polypectomy). Obstet Gynecol Clin North Am. Jun 2000;27(2):327-37, vii. [Medline].

  17. Daniell JF, Kurtz BR, Ke RW. Hysteroscopic endometrial ablation using the rollerball electrode. Obstet Gynecol. Sep 1992;80(3 Pt 1):329-32. [Medline].

  18. Propst AM, Liberman RF, Harlow BL, Ginsburg ES. Complications of hysteroscopic surgery: predicting patients at risk. Obstet Gynecol. Oct 2000;96(4):517-20. [Medline].

  19. Schenk LM, Coddington CC 3rd. Laparoscopy and hysteroscopy. Obstet Gynecol Clin North Am. Mar 1999;26(1):1-22, v. [Medline].

  20. Dickersin K, Munro MG, Clark M, et al. Hysterectomy compared with endometrial ablation for dysfunctional uterine bleeding: a randomized controlled trial. Obstet Gynecol. Dec 2007;110(6):1279-89. [Medline].

  21. Abbott JA, Garry R. The surgical management of menorrhagia. Hum Reprod Update. Jan-Feb 2002;8(1):68-78. [Medline].

  22. Balmaceda JP, Ciuffardi I. Hysteroscopy and assisted reproductive technology. Obstet Gynecol Clin North Am. Sep 1995;22(3):507-18. [Medline].

  23. Varasteh NN, Neuwirth RS, Levin B, Keltz MD. Pregnancy rates after hysteroscopic polypectomy and myomectomy in infertile women. Obstet Gynecol. Aug 1999;94(2):168-71. [Medline].

  24. Spiewankiewicz B, Stelmachow J, Sawicki W, Cendrowski K, Wypych P, Swiderska K. The effectiveness of hysteroscopic polypectomy in cases of female infertility. Clin Exp Obstet Gynecol. 2003;30(1):23-5. [Medline].

  25. Perez-Medina T, Bajo-Arenas J, Salazar F, Redondo T, Sanfrutos L, Alvarez P. Endometrial polyps and their implication in the pregnancy rates of patients undergoing intrauterine insemination: a prospective, randomized study. Hum Reprod. Jun 2005;20(6):1632-5. [Medline].

  26. Shokeir TA, Shalan HM, El-Shafei MM. Significance of endometrial polyps detected hysteroscopically in eumenorrheic infertile women. J Obstet Gynaecol Res. Apr 2004;30(2):84-9. [Medline].

  27. Stamatellos I, Apostolides A, Stamatopoulos P, Bontis J. Pregnancy rates after hysteroscopic polypectomy depending on the size or number of the polyps. Arch Gynecol Obstet. May 2008;277(5):395-9. [Medline].

  28. Lass A, Williams G, Abusheikha N, Brinsden P. The effect of endometrial polyps on outcomes of in vitro fertilization (IVF) cycles. J Assist Reprod Genet. Sep 1999;16(8):410-5. [Medline].

  29. Isikoglu M, Berkkanoglu M, Senturk Z, Coetzee K, Ozgur K. Endometrial polyps smaller than 1.5 cm do not affect ICSI outcome. Reprod Biomed Online. Feb 2006;12(2):199-204. [Medline].

  30. Batioglu S, Kaymak O. Does hysteroscopic polypectomy without cycle cancellation affect IVF?. Reprod Biomed Online. Jun 2005;10(6):767-9. [Medline].

  31. Donnez J, Jadoul P. What are the implications of myomas on fertility? A need for a debate?. Hum Reprod. Jun 2002;17(6):1424-30. [Medline].

  32. Practice Committee of American. Society for Reproductive Medicine in collaboration with Society of Reproductive Surgeons. Myomas and reproductive function. Fertil Steril. Nov 2008;90(5 Suppl):S125-30.

  33. Di Spiezio Sardo A, Mazzon I, Bramante S, Bettocchi S, Bifulco G, Guida M. Hysteroscopic myomectomy: a comprehensive review of surgical techniques. Hum Reprod Update. Mar-Apr 2008;14(2):101-19. [Medline].

  34. Vercellini P, Zaina B, Yaylayan L, Pisacreta A, De Giorgi O, Crosignani PG. Hysteroscopic myomectomy: long-term effects on menstrual pattern and fertility. Obstet Gynecol. Sep 1999;94(3):341-7. [Medline].

  35. Pritts EA. Fibroids and infertility: a systematic review of the evidence. Obstet Gynecol Surv. Aug 2001;56(8):483-91. [Medline].

  36. Somigliana E, Vercellini P, Benaglia L, Abbiati A, Barbara G, Fedele L. The role of myomectomy in fertility enhancement. Curr Opin Obstet Gynecol. Aug 2008;20(4):379-85. [Medline].

  37. Benecke C, Kruger TF, Siebert TI, Van der Merwe JP, Steyn DW. Effect of fibroids on fertility in patients undergoing assisted reproduction. A structured literature review. Gynecol Obstet Invest. 2005;59(4):225-30. [Medline].

  38. Goldrath MH. Hysteroscopic endometrial ablation. Obstet Gynecol Clin North Am. Sep 1995;22(3):559-72. [Medline].

  39. Friedler S, Margalioth EJ, Kafka I, Yaffe H. Incidence of post-abortion intra-uterine adhesions evaluated by hysteroscopy--a prospective study. Hum Reprod. Mar 1993;8(3):442-4. [Medline].

  40. Broome JD, Vancaillie TG. Fluoroscopically guided hysteroscopic division of adhesions in severe Asherman syndrome. Obstet Gynecol. Jun 1999;93(6):1041-3. [Medline].

  41. Bacsko G. Uterine surgery by operative hysteroscopy. Eur J Obstet Gynecol Reprod Biol. Feb 1997;71(2):219-22. [Medline].

  42. Taylor E, Gomel V. The uterus and fertility. Fertil Steril. Jan 2008;89(1):1-16. [Medline].

  43. Homer HA, Li TC, Cooke ID. The septate uterus: a review of management and reproductive outcome. Fertil Steril. Jan 2000;73(1):1-14. [Medline].

  44. Mollo A, De Franciscis P, Colacurci N, Cobellis L, Perino A, Venezia R. Hysteroscopic resection of the septum improves the pregnancy rate of women with unexplained infertility: a prospective controlled trial. Fertil Steril. Jun 2009;91(6):2628-31. [Medline].

  45. Pabuccu R, Onalan G, Kaya C, Selam B, Ceyhan T, Ornek T. Efficiency and pregnancy outcome of serial intrauterine device-guided hysteroscopic adhesiolysis of intrauterine synechiae. Fertil Steril. Nov 2008;90(5):1973-7. [Medline].

  46. Ozgur K, Isikoglu M, Donmez L, Oehninger S. Is hysteroscopic correction of an incomplete uterine septum justified prior to IVF?. Reprod Biomed Online. Mar 2007;14(3):335-40. [Medline].

  47. Nathani F, Clark TJ. Uterine polypectomy in the management of abnormal uterine bleeding: A systematic review. J Minim Invasive Gynecol. Jul-Aug 2006;13(4):260-8. [Medline].

  48. American College of Obstetricians and Gynecologists. ACOG practice bulletin. Alternatives to hysterectomy in the management of leiomyomas. Obstet Gynecol. Aug 2008;112(2 Pt 1):387-400. [Medline].

  49. Emanuel MH, Wamsteker K, Hart AA, Metz G, Lammes FB. Long-term results of hysteroscopic myomectomy for abnormal uterine bleeding. Obstet Gynecol. May 1999;93(5 Pt 1):743-8. [Medline].

  50. Campo S, Campo V, Gambadauro P. Short-term and long-term results of resectoscopic myomectomy with and without pretreatment with GnRH analogs in premenopausal women. Acta Obstet Gynecol Scand. Aug 2005;84(8):756-60. [Medline].

  51. Shokeir TA. Hysteroscopic management in submucous fibroids to improve fertility. Arch Gynecol Obstet. Nov 2005;273(1):50-4. [Medline].

  52. Surrey ES, Minjarez DA, Stevens JM, Schoolcraft WB. Effect of myomectomy on the outcome of assisted reproductive technologies. Fertil Steril. May 2005;83(5):1473-9. [Medline].

  53. Panel P, Grosdemouge I. Predictive factors of Essure implant placement failure: prospective, multicenter study of 495 patients. Fertil Steril. Nov 18 2008;[Medline].

  54. Rosen DM. Learning curve for hysteroscopic sterilisation: lessons from the first 80 cases. Aust N Z J Obstet Gynaecol. Feb 2004;44(1):62-4. [Medline].

  55. Nichols M, Carter JF, Fylstra DL, Childers M. A comparative study of hysteroscopic sterilization performed in-office versus a hospital operating room. J Minim Invasive Gynecol. Sep-Oct 2006;13(5):447-50. [Medline].

  56. Thiel JA, Suchet IB, Lortie K. Confirmation of Essure microinsert tubal coil placement with conventional and volume-contrast imaging three-dimensional ultrasound. Fertil Steril. Aug 2005;84(2):504-8. [Medline].

  57. Veersema S, Vleugels MP, Timmermans A, Brolmann HA. Follow-up of successful bilateral placement of Essure microinserts with ultrasound. Fertil Steril. Dec 2005;84(6):1733-6. [Medline].

  58. Connor V. Contrast infusion sonography in the post-Essure setting. J Minim Invasive Gynecol. Jan-Feb 2008;15(1):56-61. [Medline].

  59. Connor VF. Clinical experience with contrast infusion sonography as an Essure confirmation test. J Ultrasound Med. Jun 2011;30(6):803-8. [Medline].

  60. Cooper JM, Carignan CS, Cher D, Kerin JF,. Microinsert nonincisional hysteroscopic sterilization. Obstet Gynecol. Jul 2003;102(1):59-67. [Medline].

  61. Levy B, Levie MD, Childers ME. A summary of reported pregnancies after hysteroscopic sterilization. J Minim Invasive Gynecol. May-Jun 2007;14(3):271-4. [Medline].

  62. Kodaman PH, Arici A, Seli E. Evidence-based diagnosis and management of tubal factor infertility. Curr Opin Obstet Gynecol. Jun 2004;16(3):221-9. [Medline].

  63. Tulandi T, al-Took S. Endoscopic myomectomy. Laparoscopy and hysteroscopy. Obstet Gynecol Clin North Am. Mar 1999;26(1):135-48, viii. [Medline].

  64. Crane JM, Healey S. Use of misoprostol before hysteroscopy: a systematic review. J Obstet Gynaecol Can. May 2006;28(5):373-9. [Medline].

  65. Oppegaard KS, Nesheim BI, Istre O, Qvigstad E. Comparison of self-administered vaginal misoprostol versus placebo for cervical ripening prior to operative hysteroscopy using a sequential trial design. BJOG. Apr 2008;115(5):663, e1-9. [Medline].

  66. Healey S, Butler B, Kum FN, Dunne J, Hutchens D, Crane JM. A randomized trial of oral misoprostol in premenopausal women before hysteroscopy. J Obstet Gynaecol Can. Aug 2007;29(8):648-52. [Medline].

  67. Bettocchi S, Selvaggi L. A vaginoscopic approach to reduce the pain of office hysteroscopy. J Am Assoc Gynecol Laparosc. Feb 1997;4(2):255-8. [Medline].

  68. Cicinelli E, Parisi C, Galantino P, Pinto V, Barba B, Schonauer S. Reliability, feasibility, and safety of minihysteroscopy with a vaginoscopic approach: experience with 6,000 cases. Fertil Steril. Jul 2003;80(1):199-202. [Medline].

  69. Goldrath MH, Fuller TA, Segal S. Laser photovaporization of endometrium for the treatment of menorrhagia. Am J Obstet Gynecol. May 1 1981;140(1):14-9. [Medline].

  70. Lomano JM. Photocoagulation of the endometrium with the Nd:YAG laser for the treatment of menorrhagia. A report of ten cases. J Reprod Med. Feb 1986;31(2):148-50. [Medline].

  71. Richart RM, das Dores GB, Nicolau SM, Focchi GR, Cordeiro VC. Histologic studies of the effects of circulating hot saline on the uterus before hysterectomy. J Am Assoc Gynecol Laparosc. Aug 1999;6(3):269-73. [Medline].

  72. Greenberg JA. Hysteroscopic sterilization: history and current methods. Rev Obstet Gynecol. 2008;1(3):113-21. [Medline].

  73. Emanuel MH, Wamsteker K. The Intra Uterine Morcellator: a new hysteroscopic operating technique to remove intrauterine polyps and myomas. J Minim Invasive Gynecol. Jan-Feb 2005;12(1):62-6. [Medline].

  74. van Dongen H, Emanuel MH, Wolterbeek R, Trimbos JB, Jansen FW. Hysteroscopic morcellator for removal of intrauterine polyps and myomas: a randomized controlled pilot study among residents in training. J Minim Invasive Gynecol. Jul-Aug 2008;15(4):466-71. [Medline].

  75. Lin B, Akiba Y, Iwata Y. One-step hysteroscopic removal of sinking submucous myoma in two infertile patients. Fertil Steril. Nov 2000;74(5):1035-8. [Medline].

  76. Litta P, Cosmi E, Sacco G, Saccardi C, Ciavattini A, Ambrosini G. Hysteroscopic permanent tubal sterilization using a nitinol-dacron intratubal device without anaesthesia in the outpatient setting: procedure feasibility and effectiveness. Hum Reprod. Dec 2005;20(12):3419-22. [Medline].

  77. Thomson AJ, Abbott JA, Kingston A, Lenart M, Vancaillie TG. Fluoroscopically guided synechiolysis for patients with Asherman's syndrome: menstrual and fertility outcomes. Fertil Steril. Feb 2007;87(2):405-10. [Medline].

  78. Coccia ME, Becattini C, Bracco GL, Pampaloni F, Bargelli G, Scarselli G. Pressure lavage under ultrasound guidance: a new approach for outpatient treatment of intrauterine adhesions. Fertil Steril. Mar 2001;75(3):601-6. [Medline].

  79. Parsanezhad ME, Alborzi S, Zarei A, Dehbashi S, Shirazi LG, Rajaeefard A. Hysteroscopic metroplasty of the complete uterine septum, duplicate cervix, and vaginal septum. Fertil Steril. May 2006;85(5):1473-7. [Medline].

  80. Arjona JE, Mino M, Cordon J, Povedano B, Pelegrin B, Castelo-Branco C. Satisfaction and tolerance with office hysteroscopic tubal sterilization. Fertil Steril. Oct 2008;90(4):1182-6. [Medline].

  81. Bettocchi S, Ceci O, Nappi L, Di Venere R, Masciopinto V, Pansini V. Operative office hysteroscopy without anesthesia: analysis of 4863 cases performed with mechanical instruments. J Am Assoc Gynecol Laparosc. Feb 2004;11(1):59-61. [Medline].

  82. Papalampros P, Gambadauro P, Papadopoulos N, Polyzos D, Chapman L, Magos A. The mini-resectoscope: a new instrument for office hysteroscopic surgery. Acta Obstet Gynecol Scand. 2009;88(2):227-30. [Medline].

  83. Shokeir TA, Fawzy M, Tatongy M. The nature of intrauterine adhesions following reproductive hysteroscopic surgery as determined by early and late follow-up hysteroscopy: clinical implications. Arch Gynecol Obstet. May 2008;277(5):423-7. [Medline].

  84. Acunzo G, Guida M, Pellicano M, et al. Effectiveness of auto-cross-linked hyaluronic acid gel in the prevention of intrauterine adhesions after hysteroscopic adhesiolysis: a prospective, randomized, controlled study. Hum Reprod. Sep 2003;18(9):1918-21. [Medline].

  85. Guida M, Acunzo G, Di Spiezio Sardo A, Bifulco G, Piccoli R, Pellicano M. Effectiveness of auto-crosslinked hyaluronic acid gel in the prevention of intrauterine adhesions after hysteroscopic surgery: a prospective, randomized, controlled study. Hum Reprod. Jun 2004;19(6):1461-4. [Medline].

  86. Loffer FD. Contraindications and complications of hysteroscopy. Obstet Gynecol Clin North Am. Sep 1995;22(3):445-55. [Medline].

  87. Morrison DM. Management of hysteroscopic surgery complications. AORN J. Jan 1999;69(1):194-7, 199-209; quiz 210, 213-5, 21. [Medline].

  88. Borten M, Seibert CP, Taymor ML. Recurrent anaphylactic reaction to intraperitoneal dextran 75 used for prevention of postsurgical adhesions. Obstet Gynecol. Jun 1983;61(6):755-7. [Medline].

  89. Jedeikin R, Olsfanger D, Kessler I. Disseminated intravascular coagulopathy and adult respiratory distress syndrome: life-threatening complications of hysteroscopy. Am J Obstet Gynecol. Jan 1990;162(1):44-5. [Medline].

  90. Singer A, Almanza R, Gutierrez A, Haber G, Bolduc LR, Neuwirth R. Preliminary clinical experience with a thermal balloon endometrial ablation method to treat menorrhagia. Obstet Gynecol. May 1994;83(5 Pt 1):732-4. [Medline].

  91. Practice Committee of American Society for Reproductive Medicine. Indications and options for endometrial ablation. Fertil Steril. Nov 2008;90(5 Suppl):S236-40. [Medline].

  92. Valle RF, Valdez J, Wright TC, Kenney M. Concomitant Essure tubal sterilization and Thermachoice endometrial ablation: feasibility and safety. Fertil Steril. Jul 2006;86(1):152-8. [Medline].

  93. Hopkins MR, Creedon DJ, El-Nashar SA, Brown DL, Good AE, Famuyide AO. Radiofrequency global endometrial ablation followed by hysteroscopic sterilization. J Minim Invasive Gynecol. Jul-Aug 2007;14(4):494-501. [Medline].

  94. Tempany CM. From the RSNA refresher courses: Image-guided thermal therapy of uterine fibroids. Radiographics. Nov-Dec 2007;27(6):1819-26. [Medline].

  95. Bettocchi S, Ceci O, Di Venere R, Pansini MV, Pellegrino A, Marello F. Advanced operative office hysteroscopy without anaesthesia: analysis of 501 cases treated with a 5 Fr. bipolar electrode. Hum Reprod. Sep 2002;17(9):2435-8. [Medline].

  96. Blanc B. Benign expansive lesions: fibroids, polyps, and endometrial pathology--treatment by hysteroscopic resector. Eur J Obstet Gynecol Reprod Biol. Mar 1996;65(1):99.

  97. Cooper JM, Brady RM. Intraoperative and early postoperative complications of operative hysteroscopy. Obstet Gynecol Clin North Am. Jun 2000;27(2):347-66. [Medline].

  98. DeCherney AH, Diamond MP, Lavy G, Polan ML. Endometrial ablation for intractable uterine bleeding: hysteroscopic resection. Obstet Gynecol. Oct 1987;70(4):668-70. [Medline].

  99. Isaacson K. New developments in operative hysteroscopy. Obstet Gynecol Clin North Am. Jun 2000;27(2):375-83. [Medline].

  100. Litta P, Vasile C, Merlin F, Pozzan C, Sacco G, Gravila P. A new technique of hysteroscopic myomectomy with enucleation in toto. J Am Assoc Gynecol Laparosc. May 2003;10(2):263-70. [Medline].

  101. [Guideline] Loffer FD, Bradley LD, Brill AI, Brooks PG, Cooper JM. Hysteroscopic fluid monitoring guidelines. The ad hoc committee on hysteroscopic training guidelines of the American Association of Gynecologic Laparoscopists. J Am Assoc Gynecol Laparosc. Feb 2000;7(1):167-8. [Medline].

  102. Loffer FD, Bradley LD, Brill AI, Brooks PG, Cooper JM. Hysteroscopic training guidelines. The ad hoc committee on hysteroscopic training guidelines of the American Association of Gynecologic Laparoscopists. J Am Assoc Gynecol Laparosc. Feb 2000;7(1):165. [Medline].

  103. Neuwirth RS, Duran AA, Singer A, MacDonald R, Bolduc L. The endometrial ablator: a new instrument. Obstet Gynecol. May 1994;83(5 Pt 1):792-6. [Medline].

  104. Onbargi LC, Hayden R, Valle RF, Del Priore G. Effects of power and electrical current density variations in an in vitro endometrial ablation model. Obstet Gynecol. Dec 1993;82(6):912-8. [Medline].

  105. Serden SP. Diagnostic hysteroscopy to evaluate the cause of abnormal uterine bleeding. Obstet Gynecol Clin North Am. Jun 2000;27(2):277-86. [Medline].

  106. Vancaillie TG. Electrocoagulation of the endometrium with the ball-end resectoscope. Obstet Gynecol. Sep 1989;74(3 Pt 1):425-7. [Medline].

  107. Vulgaropulos SP, Haley LC, Hulka JF. Intrauterine pressure and fluid absorption during continuous flow hysteroscopy. Am J Obstet Gynecol. Aug 1992;167(2):386-90; discussion 390-1. [Medline].

 
Previous
Next
 
Table. Thickness of the Uterine Wall
LocationMean, mmRange, mm
Anterior wall22.517-25
Posterior wall2115-25
Fundus19.515-22
Isthmus108-12
Corpus5.54-7
Previous
Next
 
 
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.